Neurologie & Rehabilitation
Total Page:16
File Type:pdf, Size:1020Kb
2019 SUPPLEMENT 3 | 25. JAHRGANG | ISSN 0947-2177 | G 13574 | HERAUSGEBER: C. DETTMERS | P. W. SCHÖNLE | C. WEILLER Organ der NEUROLOGIE & DGNR DGNKN OEGNR REHABILITATION SGNR Neuroprotektion | Neuroplastizität | Neurologische Langzeittherapie S3 | 2019 ECNR European Congress of NeuroRehabilitation 2019 Budapest Congress Center, Budapest 09–12 October 2019 Abstracts n Oral Presentations n Posters 9 Budapest Für ein Leben in Bewegung JUNIOR Orthesenprogramm albrecht GmbH • CHIEMSEESTRASSE 81 • D-83233 BERNAU AM CHIEMSEE TELEFON: +49 (0) 8051 961 29 - 0 • TELEFAX: +49 (0) 8051 961 29 - 30 EMAIL: [email protected] • WWW.ALBRECHTGMBH.COM INTERNATIONALE SERVICE-HOTLINE: 00800 0 303 29 - 00 Posters 4th EUROPEAN CONGRESSCONTENT OF NEUROREHABILITATION S3 | 2019 (ECNR) Für ein Leben in Bewegung ECNR 5th European Congress of NeuroRehabilitation 2019 09 – 12 October 2019 Budapest Congress Center, Budapest TABLE OF CONTENTS S1 Oral Presentations OP01 – OP50 S20 Symposium Presentations S5.1 – S19.2 S24 Corporate Society Presentations CS01 – PCS08 JUNIOR S26 Best of Oral Presentations BP01 – BP08 S30 Young Experts’ Battle YE01 – YE07 Orthesenprogramm S32 Poster Presentations as a Guided Tour P001 – P080 S62 Poster Presentations as self-study only PS01 – PS94 Congress Presidents László Vécsei, University of Szeged I Department of Neurology László Csiba, University of Debrecen I Department of Neurology EFNR Executive Board / Core Organising Committee D. Muresanu (Romania) G. Sandrini (Italy) V. Hömberg (Germany) L. Saltuari (Austria) H. Binder (Austria) K. Diserens (Switzerland) Collaborating Societies EFNR The European Federation of NeuroRehabilitation Societies President: Dafin Muresanu (Romania) Academic partners – Bulgarian Society for NeuroRehabilitation Rehabilitation (RSNMR) – European Academy for Neurology (EAN) – Romanian Society for Neurorehabilitation (RoSNeRa) – Foundation of the Journal “Journal of Medicine and Life” – RoNeuro Institute for Neurological Research and Diagnostic – Foundation for the Study of Nanoneurosciences and – Society for the Study of Neuroprotection and Neuroplasticity Neuroregeneration (SSNN) – NeuroRehabilitation Section of the Hungarian Rehabilitation – World Federation of Neurology (WFN) albrecht GmbH • CHIEMSEESTRASSE 81 • D-83233 BERNAU AM CHIEMSEE Society – World Federation for NeuroRehabilitation (WFNR) TELEFON: +49 (0) 8051 961 29 - 0 • TELEFAX: +49 (0) 8051 961 29 - 30 – Romanian Society for Neuropshycological and Motor – World Stroke Organisation (WSO) EMAIL: [email protected] • WWW.ALBRECHTGMBH.COM INTERNATIONALE SERVICE-HOTLINE: 00800 0 303 29 - 00 Neurologie & Rehabilitation Supplement 3 · 2019 | A3 EDITORIAL BOARD NEUROLOGIE & REHABILITATION Neuroprotektion | Neuroplastizität | Neurologische Langzeittherapie Organ der DGNR | Deutschen Gesellschaft für Neurorehabilitation DGNKN | Deutschen Gesellschaft für Neurotraumatologie und Klinische Neurorehabilitation OEGNR | Österreichischen Gesellschaft für Neurorehabilitation SGNR | Schweizerischen Gesellschaft für Neurorehabilitation Herausgeber Wissenschaftlicher Beirat G. Krämer, Zürich Ch. Dettmers, Konstanz H. Ackermann, Bad Urach J. Liepert, Allensbach P. W. Schönle, Bad Oeynhausen E. Altenmüller, Hannover J.-P. Malin, Bochum C. Weiller, Freiburg S. Beer, Valens H. Masur, Bad Berg zabern T. Brandt, Heidelberg K.-H. Mauritz, Berlin Gastherausgeber O. Busse, Minden Th. Mokrusch, Gernsbach EFNR*, OEGNR, SGNR D. von Cramon, Leipzig H. Niemann, Bennewitz R. Dengler, Hannover M. A. Nitsche, Göttingen Herausgeber ex officio M. Dieterich, München K. Pfeifer, Erlangen Th. Platz (DGNR), Greifswald V. Dietz, Zürich J. Pichler, München M. Jöbges, (DGNKN), Bernau G. Ebersbach, Beelitz D. Pöhlau, Asbach W. Oder (OEGNR), Wien K. M. Einhäupl, Berlin M. Pohl, Pulsnitz A. Mühl (SGNR), Sion C. E. Elger, Bonn M. Prosiegel, München T. Ettlin, Rheinfelden P. Reuther, Bad Neuenahr- Rubrikherausgeber P. Flachenecker, Bad Wildbad Ahrweiler Interdisziplinäre Neurorehabilitation: P. Frommelt, Berlin S. Freivogel, Neuhausen M. Rijntjes, Freiburg Bildgebung: F. Hamzei, Bad Klosterlausnitz G. Goldenberg, München E. Ringelstein, Münster Internationale Kontakte: V. Hömberg, Bad Wimpfen H. Grötzbach, Schaufling Th. Rommel, Köln Neuropsychologie: H. Hildebrandt, Oldenburg W. Hacke, Heidelberg K. Scheidtmann, Gailingen Klinische Studien: T. Platz, Greifswald W. Huber, Aachen R. Schmidt, Konstanz Pathophysiologie und Restaurative Neurologie: H. Hummelsheim, Leipzig W. Tackmann, Wünnenberg K. M. Stephan, Waldbronn G. Ickenstein, Aue A. Tallner, Erlangen Rehamanagement, Nachsorge, Langzeitrehabilitation: W. Jost, Wolfach M. Thaut, Fort Collins, USA S. Kasper, Wien C.-W. Wallesch, Elzach W. Schupp, Herzogenaurach G. Kerkhoff, Saarbrücken F. L. Welter, Zwesten Gründungsherausgeber J. Kesselring, Valens K. R. H. von Wild, Münster P. Bülau †, Waldbreitbach E. Koenig, Bad Aibling J. Wissel, Berlin *EFNR Member Societies The EFNR is mandated by the following member societies to carry out its activities by statute: BSRM British Society for Rehabilitation Medicine DGNR Deutsche Gesellschaft für NeuroRehabilitation DSNR Dutch Society of NeuroRehabilitation OeGNR Österreichische Gesellschaft für NeuroRehabilitation SGNR Schweizerische Gesellschaft für NeuroRehabilitation SIRN Società Italiana di Riabilitazione Neurologica SSNN Society for the Study of Neuroprotection and Neuroplasticity The World Federation for NeuroRehabilitation (WFNR) is a partner organization of the European Federation of NeuroRehabilitation Societies and strongly supports the European-wide approach of the EFNR in all global matters A4 | Neurologie & Rehabilitation Supplement 3 · 2019 5th EUROPEAN CONGRESS OF NEUROREHABILITATION (ECNR) Oral Presentations nation, Kyoto, Japan, 6Teikyo Heisei University, Department of Physicothe- rapeutics, Tokyo, Japan, 7National Center for Global Health and Medicine, Department of Gastroenterology and Hepatology, Tokyo, Japan Introduction: Today, there are several thousands of thalidomiders OP01 over 50 years old living around the world and struggling with Scale for Retropulsion: A new scale to quantify postural physical disabilities, secondary diseases and physical pain. imbalance in the sagittal plane However, clinical studies on the effects of the thalidomide- 1,2 1,3 1 1,2 1,2 induced damage upon the thalidomide victims as they age have J. Bergmann , C. Krewer , N. Richter , F. Müller , K. Jahn only recently started to be conducted. In Japan, a multicenter 1Schön Klinik Bad Aibling, Bad Aibling, Germany, 2Ludwig-Maximilians survey was previously conducted from 2011 to 2014, but it did University, German Center for Vertigo and Balance Disorders, Munich, Ger- not investigate socioeconomic factors such as gaps in health many, 3Technical University Munich, Human Movement Science, Munich, care and social status between thalidomiders and the general Germany population in the same age cohort. Therefore, we newly carried out a nationwide survey focusing on the actual life situations Question: Retropulsion reflects a disturbed postural alignment in of them. the sagittal plane, similar to lateropulsion in the frontal plane. Patients and Method: Questionnaires were sent to 274 thalidomid- It is characterized by a spontaneous posterior body tilt, active ers living in Japan. Questionnaire items basically coincided backward pushing, and resistance against passive correction. with those of the Comprehensive Survey of Living Conditions So far, research on this behavior is very limited, even though it (CSLC) in the general population conducted by the Japanese seems quite frequent and relevant for neurorehabilitation. One Government. The results were compared with those of the CSLC major problem is that there is no established tool available to for individuals aged 55–59 years, which was the cohort most classify and quantify retropulsion. That’s why we initiated an similar in age to the average thalidomider in Japan. Moreover, international, interdisciplinary Delphi study to develop a clini- we examined their persistent pain in details. cal scale for retropulsion. The final Scale for Retropulsion (SRP) Results: More thalidomiders rated their health condition as rela- is a bed side test and includes four subtests (static postural con- tively bad or bad compared with the general population (20.2 % trol, reactive postural control, resistance, dynamic postural con- vs. 13.3 %, respectively). A much higher percentage of thalido- trol) which are assessed while sitting and standing. The SRP was miders reported having some health or physical problem caused translated into German following a standardized translation by a disease or wound (68.8 % vs. 32.6 %, respectively), and tha- process. The aim of this study was to investigate the relationship lidomiders more frequently visit medical and healthcare-related of the SRP with established measures for postural control. facilities. A higher proportion of thalidomiders (8.1 %) were Methods: Patients with different neurological disorders (stroke, unemployed, and thalidomiders tended to feel higher levels of SHT, Parkinson’s Disease, CIP/CIM) and postural imbalance worry and stress, especially in terms of the future. As for pain, 54 were included in this study. Within one day, the SRP was per- thalidomiders out of 173 (31.2 %) and 62 (35.8 %) felt pain every- formed by experimenter A and the Backward Disequilibrium day and occasionally respectively. The most frequently found Scale, the Berg Balance Scale, posturographic measures (static site of pain was